Citations

Clear

9 citation(s) found for "Griffing, Leroy".

Cutaneous Nodules and Inflammatory Arthritis: Two Illustrative Cases of Rare Mimics of Rheumatoid Arthritis
Yaman, Reena , DiCaudo, David J. , Pham, Michael M., Griffing, W. Leroy , Sullivan, Megan M. , Aslam, Fawad , Sullivan, Megan M , Yaman, Reena N , Sokumbi, Olayemi , Pham, Michael M., Aslam, Fawad

Mayo Clinic

Journal of Clinical Medicine | July 14, 2025 | Volume: 14 | Issue: 14 | Pages: 4940

10.3390/jcm14144940 | PMID 40725633 Get It

Background: Rheumatoid arthritis is a relatively common rheumatic disease that can present with inflammatory arthritis and subcutaneous nodules. Multicentric reticulohistiocytosis and fibroblastic rheumatism are rarer entities that also present with these features. Methods: Two cases, one of each of fibroblastic rheumatism and multicentric reticulohistiocytosis, are described highlighting characteristic clinical, radiographic, and histologic findings. A narrative review of the literature on these rarer conditions, compared with rheumatoid arthritis, is provided with a focus on articular and cutaneous findings, available information on disease presentations, and key contrasting features that can aid in diagnosis. Results: Radiographic erosion distribution and joint space narrowing, clinical nodule distribution and characteristics, and nodule histology can differ between these diseases. Conclusions: Multicentric reticulohistiocytosis and fibroblastic rheumatism should be considered in the evaluation of seronegative rheumatoid arthritis, especially in cases that do not respond predictably to standard therapies, and cutaneous nodule biopsy can aid in differentiating these three conditions.
Calcitonin Gene-Related Peptide Inhibitor Use for Migraine Associated with Exacerbation of Raynaud Phenomenon (1885)
Breen, Ilana, Brumfiel, Caitlin M. , Patel, Meera H. , Griffing, Leroy, Pittelkow, Mark R. , VanderPluym, Juliana H. , Mangold, Aaron R.

Mayo Clinic

Neurology | December 7, 2023 | Volume: 96 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.96.15_supplement.1885 Get It

Evaluation of the Safety of Calcitonin Gene-Related Peptide Antagonists for Migraine Treatment Among Adults With Raynaud Phenomenon
Breen, Ilana, Brumfiel, Caitlin M. , Patel, Meera H. , Butterfield, Richard , VanderPluym, Juliana H. , Griffing, Leroy, Pittelkow, Mark R. , Mangold, Aaron R. , Breen, Ilana D, Mangold, A R , VanderPluym, Juliana

Mayo Clinic

JAMA Network Open | April 20, 2021 | Volume: 4 | Issue: 4 | Pages: e217934

10.1001/jamanetworkopen.2021.7934 | PMID 33871613 Get It

Prevalence of Barrett's Esophagus in Female Patients With Scleroderma
Snyder, Diana L. , Griffing, W. Leroy , Umar, Sarah B. , Ramirez, Francisco C. , Kahn, Allon , Umar, Sarah, Crowell, Michael D.

Mayo Clinic

American Journal of Gastroenterology | January 13, 2021 | Volume: 116 | Issue: 3 | Pages: 517-521

10.14309/ajg.0000000000001109 | PMID 33657040 Get It

INTRODUCTION: Systemic sclerosis or scleroderma (SSc) is a chronic autoimmune disease that renders the esophagus prone to significant gastroesophageal reflux due to impaired esophageal clearance and reduced lower esophageal sphincter pressure. The reported prevalence of Barrett's esophagus (BE) in women with SSc varies from 2% to 37% and is derived from older studies with small sample sizes. We aimed to assess the prevalence of BE in a large cohort of women with SSc. METHODS: Women with SSc referred from the Mayo Clinic Arizona Rheumatology Clinic who completed esophagogastroduodenoscopy between 2002 and 2020 were included. Demographic and high-resolution manometry data were evaluated. The diagnosis of scleroderma was confirmed by an expert rheumatologist. The BE diagnosis was confirmed by an expert gastrointestinal pathologist. RESULTS: There were 235 women with SSc who underwent EGD. High-resolution manometry (HRM) was completed in 172 patients. Women with SSc with BE were significantly more likely to have scleroderma esophagus (absent contractility with hypotensive lower esophageal sphincter) on HRM than women with SSc without BE ( P = 0.018). There were 30 patients with SSc (12.8%) with histologically proven BE. Dysplasia was found in 13 (43.3%): 4 with indefinite, 7 with low grade, and 2 with adenocarcinoma. The incidence of any dysplasia was 5.3% per year (0.9% per year for adenocarcinoma). DISCUSSION: This the largest study on prevalence of BE in women with SSc, yielding a prevalence of 12.8%. Women with SSc with BE were significantly more likely to have absent contractility with hypotensive lower esophageal sphincter findings on HRM. The high prevalence and incidence of dysplasia found suggest that women with SSc should be included in the screening recommendations for BE.
S0383 Prevalence of Barrett’s Esophagus in Female Scleroderma Patients
Snyder, Diana L. , Griffing, W. Leroy , Umar, Sarah B. , Ramirez, Francisco C. , Crowell, Michael D. , Kahn, Allon

Mayo Clinic

American Journal of Gastroenterology | October 24, 2020 | Volume: 115 | Issue: 1 | Pages: S189-S190

10.14309/01.ajg.0000703580.83851.48 Get It

Individuals With Scleroderma May Have Increased Risk of Sleep-Disordered Breathing
Nokes, Brandon , Raza, Hassan , Cartin‐Ceba, Rodrigo , Lyng, Phillip J., Krahn, Lois E., Wesselius, Lewis , Jokerst, Clinton, Umar, Sarah B. , Griffing, W. Leroy , Neville, Matthew R., Parish, James M., Raza, Hassan A, Lyng, Philip J., Malhotra, Atul

Mayo Clinic

Journal of Clinical Sleep Medicine | November 14, 2019 | Volume: 15 | Issue: 11 | Pages: 1665-1669

10.5664/jcsm.8036 | PMID 31739857 Get It

The impact of gastroesophageal reflux disease symptoms in scleroderma: effects on sleep quality
Horsley‐Silva, Jennifer L. , Umar, Sarah B. , Vela, Marcelo F. , Griffing, W. Leroy , Parish, James M., DiBaise, John K. , Crowell, Michael D.

Mayo Clinic

Diseases of the Esophagus | February 1, 2019 | Volume: 32 | Issue: 5 | Pages: No page available

10.1093/dote/doy136 | PMID 30715227 Get It

The Impact of Pelvic Floor and Lower Gastrointestinal Symptoms on Quality of Life in Women With Systemic Sclerosis
Umar, Sarah B. , Griffing, Leroy, Garcia, Heidi, Foxx–Orenstein, Amy E., DiBaise, John K. , Crowell, Michael D.

Mayo Clinic

Journal of Clinical Gastroenterology | September 1, 2015 | Volume: 50 | Issue: 6 | Pages: e55-e59

10.1097/mcg.0000000000000405 | PMID 26325189 Get It

Background: Systemic sclerosis (SSc) patients with gastrointestinal (GI) involvement have a lower quality of life (QoL) and while the impact of upper GI symptoms on QoL in SSc patients has been described few data exist on the presence and impact of lower gastrointestinal (LGI) and pelvic floor symptoms in SSc. Our goal was to assess the prevalence of these symptoms in women with SSc and evaluate their impact on QoL. A secondary hypothesis was that the impact of LGI symptoms on QoL is mediated by depression. Study: Women with SSc (n=175) attending an outpatient scleroderma clinic completed multiple validated questionnaires. Pelvic floor and LGI symptoms included fecal incontinence (FI), urinary incontinence (UI), dual incontinence (DI), chronic constipation, diarrhea, and pelvic pain. The Student t tests adjusted for multiple comparisons were used to evaluate group differences at the 0.05 level. Results: Complete data were available for 160 women. FI was reported by 65, UI by 64, DI by 40, chronic constipation by 94, diarrhea by 82, and pelvic pain by 35 of SSc patients. Overall QoL was reduced in SSc patients with FI (0.96 vs. 0.63; P=0.007), UI (0.96 vs. 0.65; P=0.01), DI (1.11 vs. 0.67; P=0.002), and pelvic pain (1.01 vs. 0.70; P=0.04). Antidepressant use was reported by 26%. The negative impact on QoL in patients with pelvic floor symptoms was partially mediated by depression. Conclusions: Women with SSc suffer from an increased prevalence of LGI and pelvic floor symptoms including FI, UI, diarrhea, constipation, and pelvic pain and this effect seems to be partially mediated by depression.
Paclitaxel‐induced diffuse cutaneous sclerosis: a case with associated esophageal dysmotility, Raynaud's phenomenon, and myositis
Winkelmann, Richard R., Yiannias, James A. , DiCaudo, David J. , Trotter, Shannon C., Farhey, Yolanda, Griffing, W. Leroy , Martorano, Lisa M., Winkelmann, John C.

Mayo Clinic

International Journal of Dermatology | September 30, 2014 | Volume: 55 | Issue: 1 | Pages: 97-100

10.1111/ijd.12437 | PMID 25266415 Get It